Pharmacoepidemiology and Safety Sciences
“As a track leader of POP’s core specialty area in pharmacoepidemiology, I am excited to have the opportunity to organize the curriculum for this academic track within the POP graduate program. Our goal is to help students build a solid understanding of pharmaco-epidemiologic principles and methods, as well as develop strong reasoning, critical thinking, and analytical skills for research in this field.
In this specialty area, graduate courses are offered at all levels, from the beginning (PHA 6891), intermediate (PHA 6268), and advanced levels. These specialty courses offered by our department are complemented by foundational courses in epidemiology, biostatistics and bioinformatics. Together they provide students with knowledge and skills to conceive, design, and conduct studies that can make causal inferences on drug safety and effectiveness. Our curriculum strongly emphasizes the methodology and application of observational research methods in phase IV studies and other related applications of translational clinical sciences. In addition to didactic courses, students have training opportunities to gain hands-on experience by working with our faculty who are specialized in their fields of study, with emphasis on pediatric, geriatric, and psychiatric pharmacoepidemiology.”
– Yu-Jung “Jenny” Wei, Ph.D., M.S., assistant professor pharmaceutical outcomes and policy
Pharmacoepidemiology and Safety Sciences can be defined as the application of epidemiologic reasoning, methods, and knowledge to the study of the uses and effects of drugs in human populations.
Scientific expertise in Pharmacoepidemiology and Safety Sciences includes:
- content knowledge related to drug safety, pharmacovigilance, comparative effectiveness, drug utilization, and risk management;
- technical expertise in epidemiologic methods, measurement issues specific to drugs, clinical services, and diagnosis, and secondary data analysis.
Examples of pharmacoepidemiologic research include:
- drug safety studies (e.g, the detection of new safety concerns after drug approval);
- comparative effectiveness studies (e.g, the evaluation of);
- drug utilization studies (e.g, the description of trends in or determinants of the use of certain medications).
For further information about Pharmaocoepidemiology, please watch this video and visit the following sites:
Pharmacoepidemiology and Safety Sciences at UF